You are not currently logged in.
Access your personal account or get JSTOR access through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
An analysis of China's national essential medicines policy
Xiaodong Guan, Huigang Liang, Yajiong Xue and Luwen Shi
Journal of Public Health Policy
Vol. 32, No. 3 (August 2011), pp. 305-319
Published by: Palgrave Macmillan Journals
Stable URL: http://www.jstor.org/stable/20868814
Page Count: 15
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Although China embraced the concept of essential medicines in 1979 and issued its first National Essential Medicines List in 1982, until recently China has lacked a comprehensive national essential drug policy. In its most recent health-care reform (2009—2012), the Chinese government explicitly proposed the establishment of a national essential medicines system, and made it one of five top priorities in the coming years. We review the evolution of China's essential medicines policies, explain the importance of fully implementing the essential medicines policy, and analyze recent policy developments surrounding essential medicines.
Journal of Public Health Policy © 2011 Palgrave Macmillan Journals